
Please try another search
Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company primarily develops Felix, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, a rapid oxidative stress assay; and AI-Port. In addition, the company offers ambient temperature storage product for human sperm. Memphasys Limited was incorporated in 2006 and is based in Homebush, Australia.
Name | Age | Since | Title |
---|---|---|---|
John Andrew Gowans Seton | 58 | 2018 | Independent Chairman |
Matt Adams | - | 2017 | MD, Director & Company Secretary |
Shadi Mahassel | - | - | Member of Global Advisory Committee |
Simon Pearce | - | - | Member of Global Advisory Committee |
Jonathan Hannam | - | - | Member of Global Advisory Committee |
Ian Charles Bailey | - | 2017 | Non-Independent Director |
Lindley Edwards | - | 2024 | Non-Executive Chairperson of the Board |
David Ali | - | 2023 | CEO, MD & Executive Director |
Paul Wright | 60 | 2020 | Independent Non-Executive Director |
Marjan Mikel | - | 2025 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review